Cite
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.
MLA
Fredman, Gabrielle, et al. “Targeted Nanoparticles Containing the Proresolving Peptide Ac2-26 Protect against Advanced Atherosclerosis in Hypercholesterolemic Mice.” Science Translational Medicine, vol. 7, no. 275, Feb. 2015, p. 275ra20. EBSCOhost, https://doi.org/10.1126/scitranslmed.aaa1065.
APA
Fredman, G., Kamaly, N., Spolitu, S., Milton, J., Ghorpade, D., Chiasson, R., Kuriakose, G., Perretti, M., Farokzhad, O., & Tabas, I. (2015). Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Science Translational Medicine, 7(275), 275ra20. https://doi.org/10.1126/scitranslmed.aaa1065
Chicago
Fredman, Gabrielle, Nazila Kamaly, Stefano Spolitu, Jaclyn Milton, Devram Ghorpade, Raymond Chiasson, George Kuriakose, Mauro Perretti, Omid Farokzhad, and Ira Tabas. 2015. “Targeted Nanoparticles Containing the Proresolving Peptide Ac2-26 Protect against Advanced Atherosclerosis in Hypercholesterolemic Mice.” Science Translational Medicine 7 (275): 275ra20. doi:10.1126/scitranslmed.aaa1065.